Tech Company Financing Transactions
Bionaut Labs Funding Round
On 11/28/2022, Bionaut Labs raised $43 million in Series B financing from Khosla Ventures, Bold Capital Partners and Compound Ventures.
Transaction Overview
Company Name
Announced On
11/28/2022
Transaction Type
Venture Equity
Amount
$43,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to advance clinical development of its lead programs against malignant glioma brain tumors and Dandy-Walker Syndrome (a rare pediatric neurological disorder).
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3767 Overland Ave. 114
Los Angeles, CA 90034
USA
Los Angeles, CA 90034
USA
Phone
Website
Email Address
Overview
Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality. By creating a new medical modality of remote-controlled micro-robots called Bionauts, the company can transform the way the biopharmaceutical industry develops treatments, allowing them to engineer the therapeutic index forefficacy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Aviad Maizels
Chief Executive Officer
Michael Shpigelmacher
Chief Scientific Officer
Alex Kiselyov
Founder
Alex Shpunt
Vice President
William Loudon
Browse more venture capital transactions:
Prev: 11/28/2022: Morse Micro venture capital transaction
Next: 11/28/2022: Vektor AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs